Investors Alert: Class Action Against Kyverna Therapeutics for Securities Fraud

LOS ANGELES, Dec. 26, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz has announced that investors who have incurred significant losses can now take the lead in a securities fraud class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) KYTX.

Key Details for Potential Class Members

Class Period: February 2024 IPO
Deadline for Lead Plaintiff: February 7, 2025

Complaint Overview

The complaint alleges that during the Class Period, the Defendants did not disclose important information, including: (1) negative data related to one of their trials; (2) the risks posed by withholding adverse trial data; and (3) how their positive statements about the Company’s business were misleading and lacked a factual basis.

Next Steps for Investors

If you are a shareholder who has suffered losses, you can click here to participate. You do not need to take immediate action to become a member of the class action; you could choose to retain legal counsel or remain a passive member of the class action. To learn more about this lawsuit or for any questions regarding your rights, you can contact Frank R. Cruz at The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067, via phone at 310-914-5007, by email at info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. When inquiring by email, please include your mailing address, phone number, and number of shares purchased.

Please note that this press release might be considered Attorney Advertising in certain jurisdictions based on applicable law and ethical guidelines.

View original content to download multimedia: https://www.prnewswire.com/news-releases/kytx-investors-have-opportunity-to-lead-kyverna-therapeutics-inc-securities-fraud-lawsuit-302339352.html

SOURCE The Law Offices of Frank R. Cruz, Los Angeles